AAAAAA

   
Results: 1-8 |
Results: 8
Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation
Authors: Lipinski, E Cremer, FW Ho, AD Goldschmidt, H Moos, M
Citation: E. Lipinski et al., Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation, BONE MAR TR, 28(10), 2001, pp. 957-962
Clonotypic B cells in the peripheral blood of patients with multiple myeloma
Authors: Cremer, FW Goldschmidt, H Moos, M
Citation: Fw. Cremer et al., Clonotypic B cells in the peripheral blood of patients with multiple myeloma, BLOOD, 97(9), 2001, pp. 2913-2913
CD19(+) and CD20(+) B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8
Authors: Bosing, T Bellos, F Cremer, FW Gemmel, C Moldenhauer, G Ho, AD Goldschmidt, H Moos, H
Citation: T. Bosing et al., CD19(+) and CD20(+) B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8, LEUKEMIA, 14(7), 2000, pp. 1330-1331
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma
Authors: Cremer, FW Ehrbrecht, E Kiel, K Benner, A Hegenbart, U Ho, AD Goldschmidt, H Moos, M
Citation: Fw. Cremer et al., Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma, BONE MAR TR, 26(8), 2000, pp. 851-858
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
Authors: Kiel, K Cremer, FW Rottenburger, C Kallmeyer, C Ehrbrecht, E Atzberger, A Hegenbart, U Goldschmidt, H Moos, M
Citation: K. Kiel et al., Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation, BONE MAR TR, 23(10), 1999, pp. 1019-1027
Clonotypic CD20(+) and CD19(+) B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation
Authors: Rottenburger, C Kiel, K Bosing, T Cremer, FW Moldenhauer, G Ho, AD Goldschmidt, H Moss, M
Citation: C. Rottenburger et al., Clonotypic CD20(+) and CD19(+) B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation, BR J HAEM, 106(2), 1999, pp. 545-552
Autografting with CD34(+) peripheral blood stem cells: retained engraftment capability and reduced tumour cell content
Authors: Voso, MT Hohaus, S Moos, M Pforsich, M Cremer, FW Schlenk, RF Martin, S Hegenbart, U Goldschmidt, H Haas, R
Citation: Mt. Voso et al., Autografting with CD34(+) peripheral blood stem cells: retained engraftment capability and reduced tumour cell content, BR J HAEM, 104(2), 1999, pp. 382-391
Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G-CSF do not bear Kaposi's sarcoma associated herpesvirus DNA
Authors: Bellos, F Cremer, FW Ehrbrecht, E Goldschmidt, H Moos, M
Citation: F. Bellos et al., Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G-CSF do not bear Kaposi's sarcoma associated herpesvirus DNA, BR J HAEM, 103(4), 1998, pp. 1192-1197
Risultati: 1-8 |